Granular cell tumors are benign, relatively rare lesion s that can occur in any organ in the body. Tumors are known to occasionally arise in two or more different organs. We report the case of a 60-year-old woman in whom granular cell tumors arose almost simultaneously in her subcutaneo us cervical region and her IGJ )'nx. The two tumors were surgically resected and examined histopathologically, and they exhibited the same histopathologic f eatures. The tumor of the IGJ )'nx was resected with the help of a carbon dioxide laser. Immunohistochemical stainin g revealed that both were positi ve fo r S-IOO protein and neuron-specific enolase. Cases of the nearly simultaneous appearance of granular cell tumors in the neck and larynx are rather unusual. The results ofimmunohistochemical stainin g suggested that this tumor originates in nerve tissue.
Introduction
Granu lar cell tumors are benign, relatively rare lesion s that can arise in any organ in the body. They were first reported by Abrikossoff in 1926.' They have a predilection for the skin and tongue, but can also arise in the larynx. Granular cell tumors occa sionally arise at two or more sites simultaneously. However , it is relatively rare for multiple granular cell tumors to arise almost simultaneou sly in the larynx and in an extra laryngeal region . There was no significant difference in the proportion of patients reporting adverse events" Both t reatments proved to be safe in this pediatric population (n=238) and incidence of reported serious adverse events was low. The most frequent adverse events were vomiting, diarrhea, fever and rash."
• Tympanocentesis was performed at preliminary visit and again at day 4 , 5 or 6 for bacteriologic evaluatio n of middle ear fluid (MEF). t Patients were treated with either a 1()-day course of Augmentin, 45 /6.4 g/kg/day q12h, or Zithr omax, 10 mg/kg in a single dose on day 1 followed by 5 mg/kg/day q24 h on days 2 to 5. :j: Zithromax (azithromycin) is a registered trademark of Pfizer Labs Division, Pfizer Inc. § For susceptib le strains of indicated organisms. Augm entin is appropriate initi al therapy when you suspect [)-iactamase-producing pathogens.
II Clinical success defined as the number of evaluable patients that achieved either improved or compiete resolution of specific symptoms of acute otitis media and otosco pic signs of acute infection with infiammation, with or without middle ear effusion, such that no additional antibiotic therapy was required. This organism does not produce [)-Iactamase and is therefore susceptible to amoxiciliin alone. Empiric therapy with Augmentin may be inst ituted when there is reason to believe the infection may involve j}lactamase-producing pathogens. Once the results are known, therapy should be adjusted, if appropriate. The success rate of Augmentin was higher than the success rate for Zithromax in the eradication of S. pneumoniae. However, since this stud y was powered for the primary endpoint (bacteriologic eradication of H. influenzae ), there was an insufficie nt number of patie nts with S. pneumoniae-med iate d infections included to produce statist ical significance (P=O.0953).
Please see brief summ ary of presc rib ing information on adjac ent page for contralndlcatlons , warn ings , precaution s, adverse reactions, and dosage and adm inistration. Due to the different amoxicilli n to cl avulani c acid ratios in the Augmentin 250 mg tablet (250/125)versustha Augmentin250mg chewable tablet (250 /62.5) , the Augmentin250mgtablet should not be used until the pediatric patient weighs at least 40kg or more. Hepaticall y impaired pat ientsshould be dosed with caution andhepaticfunc tionmonitoredat regular interva ls. ISee WARNINGS.) Administralion: Augmentin maybetaken without regard to meals; however. abs orpti onof clavul anate potass i u~is en .hanced when Augmentin i~administered at the startof a meal. Tominimize thepotential forgastrointestinalIntole rance, Augmenrmshould betaken at the start ot a meal. BRS·AGAL6/Pl6A evidenceof harmto the fetus due to Augmentin. There are.however, noadequate and well -controlled studiesin preg .nant women. Because ani mal reproduction studiesarenot alwayspredictiveof humanresponse. usethis drugduring pregnancy only if clearlyneeded LaborandDelivery: Or al ampicillin classantibioticsaregenerally poorly absorbedduringlabor . St udies in guinea pigshave shown that intravenous administration of amp icillin decreased the uteri ne tone. frequency of contractions. height of contractionsanddueticnof con tract ions. However. it is not known whether theuseof Augmentin in humans during labo r or deliveryhasimmedi ate Ordelayed adverse effects on the fetus, prolongs the dura tionof labor . or increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of the newborn wiltbe necessarv. Nursing Mothers: Ampicillin classantibioticsareexcreted inthemil k; therefore,caution shouldbeexercised when Augmentin is administered to a nursing woman Ped .iatri c Use: In.completelydeveloped renalfunctioninneon~les andyounginfants maydelaytheetimination of arnoxicilhn. Dosing of Augmentin should be modified in pediatric patients youngerthan12 weeks 13 monthsl.lSeeDOSAGE ANDADMINISTRATION-Pediat ric.! ADVERSE REACTIONS: Augmentin isgene rallywelltolerated. The maj orityof sideeffec ts observed in clinicaltrialsweremild and transient; <3%of patients discontinued therapybecause of drug-rel atedSide effect s.From theoriginalpremarket ingstudies . where bothped iatricandadul t patientswereenrolled. the mos t frequently reported adverseeffects were diarr hea/loose stools{9%t nausea 13%1. skinrashes and urticaria (3%1. vomiting (1%) andvagini tis I1%J. Theoverall incidence of sideeffects. andin part icular diarrhea. increased with thehigher recommendeddose. Other lessfrequently reported reactions incl ude: abd ominal discomfort. flatulen ceandheadache. Thefollowingadversereactionshavebeen reported foramp icillinclassantibloucs : Diarrhea, nausea. vomiting, indigestion. gastrit is.stomatitis.glossitis. black-hairy-tongue. mucocuteneouscandidiasis, enterocolitis. andhemorrhagic/ pseudomembranouscolitis.Onset of pseudomembranous coli tissymptoms mayoccur during or after antibiotic treatment. {SeeWARNINGS,1 Ski n rashes. pruritus, urticaria. ang ioedema. serumsickness-like reactions (urticaria or skinrash accompanied by arthr itis. arthralgia.myalgiaandfrequently fever). erythemamultilorme(rarely Stevens-Johnson Syndrome! andan occasional case of exfoliative dermadtlsImcluuinq toxi c eccerma l recmlvsisl. These reactions maybe con trolledwith antihistaminesand. if necessary. sys temic cort icosteroids.Whenever such reactionsoccur, thedrugshou ldbedisc onti nued,un!ess theopinionofthephysiciandicta tesothelWise.Seriousandoccasional fatal hypersensitivity [anaphylactic)reac tionscanoccurwith oral penicillin. ISeeWAANINGS_) A moderate risein ASTISGOTI and/orALTISGPTj hasbeen notedin patients treatedwith ampicillin class antibioticsbut thesignificance of these findings is unk nown . Hepatic dysfu nct ion.includingincreases in serum transemlnases lAST and /or AlT). serum bilirubin and /or alkaline phosphatase, hasbeen infreq uently reportedwith Augmentin. It hasbee n reportedmorecommonly in theelderly. in males. or in patientson prolonged treatment. Thehistologicfindings on liver biopsyhave consistedof predominantly chclestenc. hepatoceliular.ormixedcholestatic·hepatocellularchanges. Theonset of signs/symptoms of hepatic dys· function mayoccur duringorseveral weeksaltertherapyhasbeen discontinued. Thehepaticdysfunction. which maybesevere. is usually reversible. Onrareoccasions. deaths have beenreported (less than 1 death reportedper est imate d 4 millionprescriptions worldwide). These have generallybeen cases esseelatedwith ser iousunder lyingdiseases or concomitant med ications . Interstitial nephritis and hematuria have been reported rarely. Anem ia.includinghemolyticanem ia,thrombocyt openia. thrombocytopenic pur · pore. eosinophi lia. leukopenia and agranulocytosis hav e been reported during therapy with penicillins. These react ionsareusually reversibleondiscontinuat ionof therapy and arebelieve d to behypersensitivity phenomena. A slight tbrombocvtosis was noted in les~than1% of the patients treated with Aug· mentin. There have been reports of increased prothrombin time in patients receiving Augmentin andanti-coa~u la n t therapy c oncomi t~n tly. Agitati .on, anxiety. behavioral changes. confusion. convu lsions , dizziness. insomnia andreversible hyperactIvityhave been reported rarely.
Augmentin®:

DOSAGE ANDADMINISTRATION
Since boththe Augment in 250mg and 500mgtablets contain the same amount of clavulanic acid 1125 mg. as the potassium saltl. 2 Augmentin 2SO mg tablets are not equivalent to 1 Augment in500mg tablet Therefore, 2 Augmentin250mgtablets shouldnot be substituted for 1 Augmentin500mgtablet Tha AugmentinZSO mgtebtet and the 250mg chewable teblet do notcontain the same amount of clavulanic acid (as the potassium salt or pharynx, nor were any similar lesions detected anywhere else. The patient was readmitted in August 1997, and the tumor was resected by endolaryngeal microscopic laryngosurgery with a direct laryngoscope under general anesthesia. The mass was a grayish-white, angular, exophytic 5-mm tumor located at the posterior end ofthe right ventricular fold in the right supraglottic area (figure 2). The tumor was extremely firm and difficult to resect with forceps . The periphery of the tumor was vaporized with lOW of noncontinuous irradiation deli vered by a carbon dioxide' laser, and the tumor was completely resected (figure 3). The patient had an uneventful postoperative course, and she has been followed ever since , with no sign of a recurrence of the laryngeal tumor.
Histopathologicfindings. The tumor resected from the neck measured 30 x 30 x 25 mm, and the cut surface was solid and grayish -white. Hematoxylin and eosin staining revealed the absence of any capsule enveloping the tumor cells, although the tumor was subdivided by fibrous tissue. The cell s had small hyperchromatic nuclei that did not contain nucleoli. The cytoplasm of these cells contained acidophilic granules. The large tumor cells had a "foamy" appearance ( figure 4 ). Pseudoepitheliomatous hyperplasia was not observed. Immunohistochemical staining was positive for 5-100 protein ( figure 5 ) and neuron-specific enolase. The laryngeal tumor exhibited histopathologic characteristics similar to those observed in the neck tumor. Based on these finding s, both tumors were histopathologically diagnosed as benign granular cell tumors.
Discussion
Granular cell tumors are rare subcutaneous or subepitheliallesions that arise in a variety of organ s throughout the body . The most common anatomic sites are the skin , including the subcutaneous regions, and the tongue. >' The se tumors might also arise at locations in the airway, including the larynx, trachea, and bronchi." ? About 200 cases of granular cell tumors of the larynx have been reported in the English-language literature." ! and they account for more than 10% of all granular cell tumors. 12 .1 3 Granular cell tumors of the larynx usually occur during the fourth to seventh decades , and their incidence is twice as high in men as in women. P :" By contrast, the sex incidence of this tumor in the rest of the body is just the opposite: about twice as high in women as in men.' The most common sites ofoccurrence within the larynx are the posterior third of the vocal folds and the posterior glottis. 8 • 12 • 14 The laryngeal tumor in our case arose in the supraglottic posterior portion of the ventricular fold. Although this site is adjacent to the posterior glottis, the supraglottis is considered a relatively uncommon site for these tumors .P:"
The incidence of multiple granular cell tumors has been reported to account for between 5.4 and 16% of all cases of granular cell tumors .v": " There have been relatively few reports of multiple granular cell tumors arising in the larynx and extralaryngeal sites; when they do occur almost simultaneously, they usually involve the larynx and the trachea or bronchi.5,6 There have also been case reports of simultaneous multiple tumors ofthe upper aerodigestive tract that involved the larynx .v" Accordingly, it is more proper to define simultaneous multiple tumors that include the larynx as "multicentric lesions in the region of the airway or upper aerodigestive tract." Multiple granular cell tumors that arise simultaneously in the subcutaneous cervical region and in the larynx, as in our case, appear to be relatively rare .
Granular cell tumors are usually grayi sh-white and extremely hard . lO , 16 Histopathologically, they are unencapsulated, they demonstrate the proliferation of large cells possessing cy toplasm that contains an abundance of acidophilic granules, and they are subdivided by fibrou s tissue." Moreover, the presence of the acidophilic granules gives the tumor cells a foamy appearance? and a diastase-resistance periodic acid Schi ff reaction. 8.9 Prominent squamous epithelial hyperplasia is sometimes observed in the epithelium coverin g the tumor. Thi s is referred to as pseudoepitheliomat ous hyperplasiaP:":" and it is especially common in the larynx.19.20 When this site is biopsied, it ca n be difficult to distingui sh this tumor from squamous cell carcinoma.i:" In our patient , the histopathologic findings were associated with these characteristics in both the subcutaneous cervi cal tumor and the laryngeal tumor, but pseudoepitheliomatous hyperplasia was not obser ved.
The origin of granular cell tumors has not yet been clearly identified. However, on immunohistochemical staining, most of them are positiv e for S-l 00 protein and neuron-specific enolase, which suggests that these tumors originate in nerve tissue. Specifically, these findin gs support the hypothesis that these tumo rs origin ate in peripheral nerve Sch warm cells. 2 1.22 Recent immun ohi stochemical studies have shown that the expression of the lysosome-associated glycoprotein CD68 is comm on to both granular cell tumors and schwannom as, which lend s even more support to the hypothesis that granular cell tumo rs arise from Sch wann cells." Malignant transformation of granular cell tumors is rare (1 to 2% of all cases), and only 35 cases have been reported in the Engli sh-language literature."
The treatment of choice for granular cell tumors is surgic al resection, with histologically negative margin s. In the larynx , relativ ely small tumors can be resec ted by endolaryngeal micro scopic laryngo surgery with a direct laryngoscope. Large tumors should be resected by a 164 laryngofi ssure approach. The recurrence rate follo wing appropriate resection has been reported to be 8%.ISHowever, in cases of positive-margin resection s, recurrence rates in the head and neck have been as high as 21 to 50%. 25 The laryngeal tumor in our case was resected by endolaryngeal micro scopi c laryngosurgery. Bec ause the tumor was extremely hard, it was diffi cult to resect it completely using only forcep s. Accordin gly , we attempted to exc ise it while vapori zing the surro unding mucou s membrane with a carbon dioxid e laser. There was little bleed ing, and we were able to ensure an adequate margin of resection.
We conclude that laser surge ry is extremely useful for resecting granular cell tumo rs of the laryn x. Mo re than 2 years after surgically resecting the laryngeal tumor in our patient, we have seen no evidence of recurrenc e. Even so, long-term followup is necessary. Finally, when ever a granular cell tumor is found in one orga n, oth er organs throu ghout the body should be closely examined for othe r tumors.
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